David Ziegler
University of California, San Francisco · Sydney Children's Hospital - Australian Study Chair · SCHN
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name David Ziegler as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-11 21:09 UTC. Open this list on ClinicalTrials.gov
- N/ANCT06633952 · Accelerating Cognitive Gains From Digital Inverventions With Noninvasive Brain StimulationUniversity of California, San Francisco · active not recruiting · Aging, MCI · principal investigator
- N/ANCT06397469 · Enhancing Attention and Wellbeing Using Digital TherapeuticsUniversity of California, San Francisco · recruiting · Aging, MCI, Cognitive Decline · principal investigator
- Ph1/Ph2NCT06208657 · Optimal Precision TherapIes to CustoMISE Care in Childhood and Adolescent CancerAustralian & New Zealand Children's Haematology/Oncology Group · recruiting · Childhood Cancer, Childhood Solid Tumor, Childhood Brain Tumor · study chair
- N/ANCT05504772 · Precision Medicine for Every Child With CancerAustralian & New Zealand Children's Haematology/Oncology Group · recruiting · Childhood Cancer, Childhood Solid Tumor, Childhood Brain Tumor · principal investigator
- N/ANCT03722784 · Evaluation of Silicone Hydrogel Daily Wear Contact Lenses for Up to One (1) Month of Daily WearCooperVision, Inc. · completed · Myopia, Hyperopia, Astigmatism · principal investigator
- N/ANCT03336931 · PRecISion Medicine for Children With CancerSydney Children's Hospitals Network · active not recruiting · Childhood Cancer, Childhood Solid Tumor, Childhood Brain Tumor · principal investigator
- Ph1NCT02687386 · A Study of Intravenous EEDVsMit in Children With Recurrent / Refractory Solid or CNS Tumours Expressing EGFRDr David Ziegler · terminated · Solid Tumours, CNS Tumours · study chair
Grants
NIH projects from RePORTER, fetched 2026-11-11 21:09 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
- Optimizing a closed-loop digital meditation intervention for remediating cognitive decline and reducing stress in older adultsR01AG076668 · NIA · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · fiscal years 2022 to 2026 · $1,388,705 awarded in 2026Grant number is on one of their registry trials
- A Pilot Study of the Impact of Personalized Digital Meditation on Improving Cognition and Sleep and Reducing Stress in MCIR61AG083503 · NIA · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · fiscal years 2023 to 2024 · $524,875 awarded in 2024Same name and institution; not confirmed by an ID
- Accelerating Cognitive Gains from Digital Meditation with Noninvasive Brain Stimulation: A Pilot Study in MCIR61AG080528 · NIA · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · fiscal years 2023 to 2024 · $524,623 awarded in 2024Grant number is on one of their registry trials
Most cited trial papers
Clinical-trial papers with this author name, ranked by citations from NIH iCite, fetched 2026-11-11 21:09 UTC. The ranking covers the 200 most relevant of 109 PubMed records, and a shared surname and initials can bring in a namesake. All 109 on PubMed
- Treatment of symptomatic diabetic peripheral neuropathy with the anti-oxidant alpha-lipoic acid. A 3-week multicentre randomized controlled trial (ALADIN Study).Diabetologia · 1995408 citationsRCR 13.1
- Oral treatment with alpha-lipoic acid improves symptomatic diabetic polyneuropathy: the SYDNEY 2 trial.Diabetes Care · 2006377 citationsRCR 10.9
- 293 citationsRCR 8.8
- Efficacy and safety of antioxidant treatment with α-lipoic acid over 4 years in diabetic polyneuropathy: the NATHAN 1 trial.Diabetes Care · 2011262 citationsRCR 8.5
- The sensory symptoms of diabetic polyneuropathy are improved with alpha-lipoic acid: the SYDNEY trial.Diabetes Care · 2003247 citationsRCR 6.8
- Standardized tests of heart rate variability: normal ranges obtained from 309 healthy humans, and effects of age, gender, and heart rate.Clin Auton Res · 2001234 citationsRCR 7.8
- Serum antimüllerian hormone levels remain stable throughout the menstrual cycle and after oral or vaginal administration of synthetic sex steroids.Fertil Steril · 2008196 citationsRCR 6.9
- 194 citationsRCR 6.2
- The type II RAF inhibitor tovorafenib in relapsed/refractory pediatric low-grade glioma: the phase 2 FIREFLY-1 trial.Nat Med · 2024185 citationsRCR 24.9
- Direct transport of progesterone from vagina to uterus.Obstet Gynecol · 2000178 citationsRCR 6.1